{"id":1030428,"date":"2010-11-28T00:23:32","date_gmt":"2010-11-28T00:23:32","guid":{"rendered":"http:\/\/www.immortalitymedicine.tv\/low-dose-aspirin-therapy-and-hypertensive-pregnancy-complications-in-unselected-ivf-and-icsi-patients-a-randomized-placebo-controlled-double-blind-study\/"},"modified":"2024-08-17T14:58:11","modified_gmt":"2024-08-17T18:58:11","slug":"low-dose-aspirin-therapy-and-hypertensive-pregnancy-complications-in-unselected-ivf-and-icsi-patients-a-randomized-placebo-controlled-double-blind-study","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/human-reproduction\/low-dose-aspirin-therapy-and-hypertensive-pregnancy-complications-in-unselected-ivf-and-icsi-patients-a-randomized-placebo-controlled-double-blind-study.php","title":{"rendered":"Low-dose aspirin therapy and hypertensive pregnancy complications in unselected IVF and ICSI patients: a randomized, placebo-controlled, double-blind study"},"content":{"rendered":"<p>BACKGROUND<\/p>\n<p>Low-dose aspirin therapy could improve remodelling of maternal spiral arteries during early placentation and prevent subsequent pregnancy-related hypertensive disorders. We investigated whether low-dose aspirin therapy reduces the incidence of hypertensive pregnancy complications in unselected IVF and ICSI patients when medication was started prior to pregnancy.<\/p>\n<p>METHODS<\/p>\n<p>A total of 487 patients who underwent IVF\/ICSI were randomized to receive 100 mg aspirin (<I>n<\/I> = 242) or placebo (<I>n<\/I> = 245) daily, starting on the first day of gonadotrophin stimulation. Pregnant women continued the medication until delivery. A total of 107 patients (52 with aspirin and 55 with placebo) experienced live birth and were included in this follow-up study. The main outcome measure was the incidence of hypertensive pregnancy complications.<\/p>\n<p>RESULTS<\/p>\n<p>Embryo transfer took place in 227 (94%) women in the aspirin group and in 229 (93%) women in the placebo group. The live birth rate between the aspirin (22.9%) and placebo (24.0%) groups did not differ significantly (<I>P<\/I> = 0.78). The overall incidence of hypertensive pregnancy complications was 15.4% (8\/52) in the aspirin group and 18.2% (10\/55) in the placebo group (<I>P<\/I> = 0.70, 95% confidence interval for the difference of proportions &ndash;17 to 11%). There were two cases of severe pre-eclampsia in the aspirin group and three cases in the placebo group.<\/p>\n<p>CONCLUSIONS<\/p>\n<p>In the present study, the incidence of hypertensive pregnancy complications did not differ statistically significantly between low-dose aspirin and placebo groups in unselected IVF\/ICSI patients, when medication was started concomitantly with gonadotrophin stimulation and continued until delivery.<\/p>\n<p>The study was registered at clinicaltrials.gov. NCT00683202.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>BACKGROUND Low-dose aspirin therapy could improve remodelling of maternal spiral arteries during early placentation and prevent subsequent pregnancy-related hypertensive disorders. We investigated whether low-dose aspirin therapy reduces the incidence of hypertensive pregnancy complications in unselected IVF and ICSI patients when &hellip; <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/human-reproduction\/low-dose-aspirin-therapy-and-hypertensive-pregnancy-complications-in-unselected-ivf-and-icsi-patients-a-randomized-placebo-controlled-double-blind-study.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246857],"tags":[],"class_list":["post-1030428","post","type-post","status-publish","format-standard","hentry","category-human-reproduction"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1030428"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1030428"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1030428\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1030428"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1030428"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1030428"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}